# LIDOCAINE
> **ANDA217221** · Abbreviated New Drug Application (Generic) · Sponsor: DIFGEN PHARMS · Approved 2025-03-25
## Drug
- **FDA Application Number:** ANDA217221
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LIDOCAINE
- **Generic name:** Lidocaine
- **Active ingredients:** LIDOCAINE
- **Dosage form:** PATCH
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** DIFGEN PHARMS
- **First approval:** 2025-03-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217221)
---
*MORVS · CC0 1.0*